Efficacy of the Adjuvanted Recombinant Zoster Vaccine in Reducing the Duration of Zoster-Associated Pain
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
PAIN®
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials
Pain 2023 Apr 01;164(4)741-748, JH Kim, R Johnson, M Kovac, AL Cunningham, M Amakrane, KM Sullivan, AF Dagnew, D Curran, A SchuindFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.